ERRα is thought to be an important mediator of tumor growth in ER- breast cancer given that (i) high expression of this target confers negative prognostic outcomes, (ii) loss of ERRα diminishes tumor growth, and (iii) there is demonstrable crosstalk between the pathways downstream of ER and ERRα [130]. The gene discussed is ESR1; the disease is breast carcinoma.